Skip to main content

and
  1. Article

    Open Access

    The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

    Disproportionality analyses using reports of suspected adverse drug reactions are the most commonly used quantitative methods for detecting safety signals in pharmacovigilance. However, their methods and resul...

    Michele Fusaroli, Francesco Salvo, Bernard Begaud, Thamir M. AlShammari in Drug Safety (2024)

  2. Article

    Open Access

    The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

    In pharmacovigilance, disproportionality analyses based on individual case safety reports are widely used to detect safety signals. Unfortunately, publishing disproportionality analyses lacks specific guidelin...

    Michele Fusaroli, Francesco Salvo, Bernard Begaud, Thamir M. AlShammari in Drug Safety (2024)

  3. Article

    Open Access

    Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

    Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and aims to determine if there is sufficient evidence to justify f...

    Oskar Gauffin, Judith S. Brand, Sara Hedfors Vidlin, Daniele Sartori in Drug Safety (2023)

  4. No Access

    Article

    Preventability of Adverse Drug Reactions Related to Antibiotics: An Assessment Based on Spontaneous Reporting System

    Antibiotics are commonly used in both outpatient and inpatient settings and are responsible for the majority of adverse drug reaction (ADR) reports. We aimed to characterize spontaneously reported ADRs associa...

    Ha N. Tran, Tien N. T. Nguyen in Therapeutic Innovation & Regulatory Science (2023)